New Innovations in Oligonucleotide Synthesis Technology Accelerate Research and Therapeutic Applications

During the past year, the industry registered a Y-o-Y increase worth 9.6%. From 2022 to 2032, oligonucleotide synthesis demand is poised to flourish at a CAGR of 11.5% to reach a value of US$ 17 Billion by the end of 2032.

oligonucleotide synthesis Market demand is expected to grow at an 11.5% CAGR to reach US$ 17 billion by the end of 2032. The oligonucleotide synthesis market refers to the production and sale of synthetic oligonucleotides, which are short strands of nucleic acids (DNA or RNA) used for various applications in research, diagnostics, and therapeutics.

Oligonucleotide synthesis involves chemically synthesizing short sequences of nucleotides, typically ranging from 8 to 200 bases in length, using automated instruments and solid-phase synthesis techniques. These synthetic oligonucleotides are used for a wide range of applications, including PCR, gene synthesis, gene editing, RNA interference, and aptamer-based assays. The market for oligonucleotide synthesis has grown significantly in recent years, driven by the increasing demand for custom-designed oligonucleotides for research and diagnostics, as well as the development of new therapeutic applications for oligonucleotides. The market is highly competitive, with a large number of companies offering custom oligonucleotide synthesis services, as well as a variety of pre-designed oligonucleotide products for specific applications

Download Free Sample Copy of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=4853

Key Takeaways from Latin America Oligonucleotide Synthesis Market Study

• Global oligonucleotide synthesis market to treble from 2022-2032
• Synthesized oligonucleotide synthesis to be a top-selling category, capturing more than 3/5th revenue and flourishing at a 12.2% CAGR
• By application, oligonucleotide synthesis for the therapeutics to expand at a CAGR of 18.4%
• U.S to emerge as the fastest-growing Oligonucleotide Synthesis market, documenting a 10.2% CAGR
• APAC to be the 2nd most opportunistic market, expected to be valued at US$ 1.7 Billion in 2032

Key Segments Covered in the Oligonucleotide Synthesis Industry Survey

• Oligonucleotide Synthesis by Product :
  • Oligonucleotide Synthesis Reagents & Consumables
  • Oligonucleotide Synthesis Equipment
  • Synthesized Oligonucleotides:
    • DNA Oligonucleotides
    • RNA Oligonucleotides
  • Other Oligonucleotide Synthesis Products
• Oligonucleotide Synthesis by Application :
  • Research
    • Polymerase Chain Reaction (PCR)
    • Next-Generation Sequencing
    • Others
  • Therapeutics
    • Antisense Oligonucleotides
    • Nucleic Acid Aptamers
  • Diagnostics
• Oligonucleotide Synthesis by End User :
  • Biotechnology & Pharmaceutical Companies
  • Research Institutes
  • Diagnostic Laboratories

Competitive Landscape

The global market for Oligonucleotide Synthesis is characterized by the presence of multiple vendors, aiming to offer extensive consulting and integration services to clients. Additionally, enterprises are seeking out, specialized service providers, offering solutions tailor-made to suit their business objectives. In addition, the vendors are likely to leverage up-gradation and product differentiation to gain an edge over other competitors in the market.

• Thermo Fisher Scientific Inc., the world leader in serving science, and Groupe Novasep SAS (Novasep), a leading provider of services and technologies to the life sciences industry, announced in January 2021 that Thermo Fisher had completed the acquisition of Henogen S.A., Novasep’s viral vector manufacturing business in Belgium, for approximately 725 million Euro in cash.
• CordenPharma International and GE Healthcare’s Dharmacon Business announced a strategic collaboration in June 2019 to develop an end-to-end solution for oligonucleotide-based drug discovery. The collaboration addressed the time and capacity constraints that researchers face when moving from research and preclinical stages to drug development and clinical trials.

Key Companies Profiled

• Thermo Fisher Scientific Corporation
• Integrated DNA Technologies Inc.
• Sigma-Aldrich Corporation
• GE Healthcare
• Kaneka Eurogentec S.A.
• TriLink Biotechnologies LLC
• BioAutomation
• ATDBio Ltd.

Key Questions Covered in the Oligonucleotide Synthesis Market

1. What are the current market trends and drivers for the oligonucleotide synthesis market, and how are they expected to evolve in the coming years?
2. What are the major applications of synthetic oligonucleotides, and how are they used in research, diagnostics, and therapeutics?
3. Who are the key players in the oligonucleotide synthesis market, and what are their market shares and competitive strategies?
4. What are the major challenges facing the oligonucleotide synthesis market, including regulatory issues, technological limitations, and competition from other technologies?